HealthQuill Canada
Agilent Technologies Inc., will acquire Canada-based Biovectra, a contract development and manufacturing company, for $925 million, according to a company statement.
Drugs Health Pharma

US-based Agilent Technologies to acquire Canada’s Biovectra for $925m

HQ Team July 23, 2024: Agilent Technologies Inc., will acquire Canada-based Biovectra, a contract development and manufacturing company, for $925 million, according to.

Read More
AstraZeneca announced the completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, for $2.4 billion.
Drugs Health Pharma

AstraZeneca completes $2.4 billion acquisition of Fusion Pharma

AstraZeneca announced the completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, for $2.4 billion.

Read More
At least 75.9 million people were forced to flee their homes due to conflict, violence or disasters within their state’s borders in 2023, according to a UN report.
Climate Health Pharma

About 76 million people are internally displaced worldwide, says UN

HQ Team May 15, 2024: At least 75.9 million people were forced to flee their homes due to conflict, violence or disasters within.

Read More
Anglo-Swedish drugmaker, AstraZeneca will acquire clinical-stage Fusion Pharmaceuticals for $2 billion in cash to get access to the latter’s radioconjugates to treat cancer.
Drugs Health Pharma

AstraZeneca to acquire Fusion Pharmaceuticals for $2 billion in cash

HQ Team March 20, 2024: Anglo-Swedish drugmaker, AstraZeneca will acquire clinical-stage Fusion Pharmaceuticals for $2 billion in cash to get access to the.

Read More
Teenagers are using e-cigarettes at a rate higher than adults, and in England, the numbers have tripled in the past three years, according to the World Health Organization.
Drugs Health Pharma

Teenagers smoking e-cigarettes at a faster rate than adults: WHO

HQ Team December 15, 2023: Teenagers are using e-cigarettes at a rate higher than adults, and in England, the numbers have tripled in.

Read More
The WHO has reclassified the Covid-19 virus Omicron BA.2.86 mutation as a “variant of interest” after the global health agency reported an 8.9% rise in global prevalence in cases arising in the UK, France and Sweden.
Drugs Health Pharma

Omicron mutant BA.2.86 reclassified as ‘variant of interest’ by WHO 

HQ Team November 29, 2023: The WHO has reclassified the Covid-19 virus Omicron BA.2.86 mutation as a “variant of interest” after the global.

Read More
The heat waves sweeping across the globe are the “new normal” and do not come as a surprise, Alvaro Silva, a climate expert with the World Meteorological Organization said.
Climate Health Pharma

Heatwaves across Europe, the US “new normal,” says WMO 

HQ Team August 21, 2023: The heat waves sweeping across the globe are the “new normal” and do not come as a surprise,.

Read More
The WHO has updated the EG.5 variability of the COVID-19 virus to a ‘variant of interest’ — with genetic changes that are predicted or known to affect virus characteristics, such as transmissibility, virulence, antibody evasion, susceptibility to therapeutics and detectability.
Drugs Health Pharma

WHO labels Covid-19 variant EG.5 as ‘variant of interest’; cases rise

HQ Team August 10, 2023: The WHO has updated the EG.5 variability of the COVID-19 virus to a ‘variant of interest’ — with.

Read More
A new genetic variant of HIV infection, discovered after more than 25 years of research and linked to lower infection rates among people with African ancestry, may help direct future treatment of the virus, according to global researchers
Drugs Health Pharma

New African HIV gene variant may help future treatment of virus

HQ Team August 7, 2023: A new genetic variant of HIV infection, discovered after more than 25 years of research and linked to.

Read More
Migratory flows have fanned the Chagas disease, and a study of 2,820 people from the countries where it is an endemic, revealed that 47% were infected by the parasite and 17% had heart lesions.
Health Medical Pharma

Migration leading to high global prevalence of Chagas disease

HQ Team July 17, 2023: Migratory flows have fanned the Chagas disease, and a study of 2,820 people from the countries where it.

Read More
X